Universe · entity
Sofinnova Investments, Inc.
Institutional manager (13F) · CIK 1631134
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $2.0B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | Natera Inc | $310M | 1,550,280 |
| 2 | Bristol-Myers Squibb Co | $121M | 1,988,721 |
| 3 | Jazz Pharmaceuticals PLC | $113M | 598,327 |
| 4 | Vera Therapeutics Inc | $112M | 2,793,987 |
| 5 | United Therapeutics Corp | $95M | 160,070 |
| 6 | AstraZeneca PLC | $90M | 456,031 |
| 7 | Cogent Biosciences Inc | $81M | 2,113,551 |
| 8 | Ultragenyx Pharmaceutical Inc | $66M | 3,145,888 |
| 9 | Rapport Therapeutics Inc | $60M | 1,904,408 |
| 10 | Insmed Inc | $57M | 346,075 |
| 11 | Alcon AG | $55M | 729,972 |
| 12 | Supernus Pharmaceuticals | $49M | 954,309 |
| 13 | BioMarin Pharmaceutical Inc | $44M | 781,982 |
| 14 | Biogen Inc | $42M | 229,521 |
| 15 | Celcuity Inc | $42M | 366,175 |
| 16 | BioAge Labs Inc | $40M | 2,293,788 |
| 17 | Rhythm Pharmaceuticals Inc | $39M | 450,096 |
| 18 | Arrivent BioPharma Inc | $39M | 1,696,752 |
| 19 | IDEAYA Biosciences Inc | $38M | 1,131,786 |
| 20 | Immunome Inc | $37M | 1,701,904 |
| 21 | Nektar Therapeutics | $37M | 509,546 |
| 22 | Axsome Therapeutics Inc. | $36M | 212,747 |
| 23 | Immatics N.V | $36M | 3,630,454 |
| 24 | BridgeBio Pharma Inc | $30M | 409,183 |
| 25 | Dyne Therapeutics Inc | $30M | 1,633,897 |
| 26 | Inhibrx Biosciences Inc | $27M | 406,029 |
| 27 | Dexcom Inc | $25M | 393,576 |
| 28 | Pharvaris N V | $23M | 818,328 |
| 29 | Praxis Precision Medicines Inc | $21M | 63,680 |
| 30 | Genmab A/S | $20M | 752,261 |
| 31 | Arcus Biosciences Inc | $20M | 923,086 |
| 32 | Xenon Pharmaceuticals Inc | $18M | 305,216 |
| 33 | Stryker Corporation | $15M | 44,480 |
| 34 | AnaptysBio Inc | $14M | 248,253 |
| 35 | Roivant Sciences Ltd | $13M | 477,995 |
| 36 | Edgewise Therapeutics Inc | $12M | 386,498 |
| 37 | Compass Therapeutics Inc | $11M | 2,056,161 |
| 38 | Oric Pharmaceuticals Inc | $9M | 679,578 |
| 39 | Tango Therapeutics Inc | $8M | 395,081 |
| 40 | Tyra Biosciences Inc | $8M | 204,015 |
| 41 | AxoGen Inc | $7M | 210,665 |
| 42 | Definium Therapeutics Inc | $7M | 344,166 |
| 43 | Cytokinetics Inc | $6M | 91,791 |
| 44 | Disc Medicine Inc | $5M | 78,320 |
| 45 | Veradermics Inc | $5M | 73,315 |
| 46 | Harmony Biosciences Hldgs Inc | $4M | 152,695 |
| 47 | Vaxcyte Inc | $3M | 50,600 |
| 48 | Mirum Pharmaceuticals Inc | $3M | 27,591 |
| 49 | Nextcure Inc | $2M | 222,654 |
| 50 | Savara Inc | $2M | 364,763 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.